Announcement
17
SEPTEMBER
2021
Neville Registrars welcomes Biosceptre International Limited
Neville Registrars is delighted to welcome Biosceptre International Limited as the newest addition to its list of client companies.
Biosceptre is a biopharmaceutical company focused on chimeric antigen receptor (CAR) T-cell therapy and immune-oncology treatment, that’s committed to bringing a new range of targeted therapies to a wide range of cancer patients.
Further information can be found on the Company's website:https://www.biosceptre.com/
;